BYL719

Item no.	CT-BYL719-100
Manufacturer	ChemieTek
CASRN	1217486-61-7
Amount	100 mg
Quantity options	10 mg 100 mg 200 mg 50 mg 500 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>99% chem and optical purity (HPLC and Chiral HPLC at 214 and 254 nm)
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Alpelisib,NVP-BYL719
Available
Storage Conditions	Store at 0°C (short term), -20°C (long term), desiccated
Brief Description	BYL179 is an orally bioavailable, next generation PI3K α - isoform specific inhibitor, currently in clinical trials.
Original QC Data	HPLC-MS, ¹HNMR, Chiral HPLC, and Quantitative Elemental Analysis
Solubility	Soluble in DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 24 days

Compare

Add to wishlist

Get an offer